All News

2016

November

Media Release / Nov 22, 2016

Sandoz to donate up to USD 10 million of high-quality generic medicines annually to Americares to increase access to medicines

Read More
Media Release / Nov 18, 2016

Innovative study with three treatment switches confirms Sandoz biosimilar etanercept has equivalent efficacy to originator

Read More

October

Media Release / Oct 25, 2016

Novartis delivered solid third quarter with Growth Products[1] offsetting Gleevec patent expiration; several positive readouts for potential blockbusters

Read More

September

Media Release / Sep 28, 2016

Sandoz invites young entrepreneurs to enter Sandoz HACk, a global competition to help solve healthcare access challenges

Read More
Media Release / Sep 16, 2016

Top-line results for PF-06438179 (biosimilar infliximab) demonstrate equivalent efficacy to reference product

Read More

August

Media Release / Aug 31, 2016

AirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus®[1] in persistence to treatment

Read More
Media Release / Aug 30, 2016

FDA approves Sandoz Erelzi™ to treat multiple inflammatory diseases

Read More
Media Release / Aug 18, 2016

Launch of novel on-demand news service Transplant TODAY from TTS 2016 transplant congress

Read More

July

Media Release / Jul 19, 2016

Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects

Read More
Media Release / Jul 13, 2016

Sandoz biosimilar etanercept recommended by FDA advisory committee for approval to treat multiple inflammatory diseases

Read More